Patents by Inventor Syed Faiyez Ahmed Hossainy

Syed Faiyez Ahmed Hossainy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions to treat myocardial conditions
    Patent number: 8747385
    Abstract: Methods, devices, kits and compositions to treat a myocardial infarction. In one embodiment, the method includes the prevention of remodeling of the infarct zone of the ventricle. In other embodiments, the method includes the introduction of structurally reinforcing agents. In other embodiments, agents are introduced into a ventricle to increase compliance of the ventricle. In an alternative embodiment, the prevention of remodeling includes the prevention of thinning of the ventricular infarct zone. In another embodiment, the prevention of remodeling and thinning of the infarct zone involves the cross-linking of collagen and prevention of collagen slipping. In other embodiments, the structurally reinforcing agent may be accompanied by other therapeutic agents. These agents may include but are not limited to pro-fibroblastic and angiogenic agents.
    Type: Grant
    Filed: May 10, 2012
    Date of Patent: June 10, 2014
    Assignee: Abbott Cardiovascular Systems Inc.
    Inventors: Eugene T. Michal, Evgenia Mandrusov, Charles D. Claude, Ni Ding, Murthy Simhambhatla, Syed Faiyez Ahmed Hossainy, Srinivasan Sridharan, Paul Consigny
  • Methods and compositions to treat myocardial conditions
    Patent number: 8383158
    Abstract: Methods, devices, kits and compositions to treat a myocardial infarction. In one embodiment, the method includes the prevention of remodeling of the infarct zone of the ventricle. In other embodiments, the method includes the introduction of structurally reinforcing agents. In other embodiments, agents are introduced into a ventricle to increase compliance of the ventricle. In an alternative embodiment, the prevention of remodeling includes the prevention of thinning of the ventricular infarct zone. In another embodiment, the prevention of remodeling and thinning of the infarct zone involves the cross-linking of collagen and prevention of collagen slipping. In other embodiments, the structurally reinforcing agent may be accompanied by other therapeutic agents. These agents may include, but are not, limited to pro-fibroblastic and angiogenic agents.
    Type: Grant
    Filed: April 15, 2003
    Date of Patent: February 26, 2013
    Assignee: Abbott Cardiovascular Systems Inc.
    Inventors: Eugene T. Michal, Evgenia Mandrusov, Charles D. Claude, Ni Ding, Murthy Simhambhatla, Syed Faiyez Ahmed Hossainy, Srinivasan Sridharan, Paul Consigny
  • METHODS AND COMPOSITIONS TO TREAT MYOCARDIAL CONDITIONS
    Publication number: 20120219521
    Abstract: Methods, devices, kits and compositions to treat a myocardial infarction. In one embodiment, the method includes the prevention of remodeling of the infarct zone of the ventricle. In other embodiments, the method includes the introduction of structurally reinforcing agents. In other embodiments, agents are introduced into a ventricle to increase compliance of the ventricle. In an alternative embodiment, the prevention of remodeling includes the prevention of thinning of the ventricular infarct zone. In another embodiment, the prevention of remodeling and thinning of the infarct zone involves the cross-linking of collagen and prevention of collagen slipping. In other embodiments, the structurally reinforcing agent may be accompanied by other therapeutic agents. These agents may include but are not limited to pro-fibroblastic and angiogenic agents.
    Type: Application
    Filed: May 10, 2012
    Publication date: August 30, 2012
    Applicant: Abbott Cardiovascular System Inc.
    Inventors: Eugene T. Michal, Evgenia Mandrusov, Charles D. Claude, Ni Ding, Murthy Simhambhatia, Syed Faiyez Ahmed Hossainy, Srinivasan Sridharan, Paul Consigny
  • Methods and compositions to treat myocardial conditions
    Patent number: 7641643
    Abstract: Methods, devices, kits and compositions to treat a myocardial infarction. In one embodiment, the method includes the prevention of remodeling of the infarct zone of the ventricle. In other embodiments, the method includes the introduction of structurally reinforcing agents. In other embodiments, agents are introduced into a ventricle to increase compliance of the ventricle. In an alternative embodiment, the prevention of remodeling includes the prevention of thinning of the ventricular infarct zone. In another embodiment, the prevention of remodeling and thinning of the infarct zone involves the cross-linking of collagen and prevention of collagen slipping. In other embodiments, the structurally reinforcing agent may be accompanied by other therapeutic agents. These agents may include but are not limited to pro-fibroblastic and angiogenic agents.
    Type: Grant
    Filed: April 15, 2003
    Date of Patent: January 5, 2010
    Assignee: Abbott Cardiovascular Systems Inc.
    Inventors: Eugene T. Michal, Evgenia Mandrusov, Charles D. Claude, Nadine Ding, Murthy Simhambhatla, Syed Faiyez Ahmed Hossainy, Srinivasan Sridharan, Paul Consigny
  • Methods and compositions to treat myocardial conditions
    Publication number: 20040208845
    Abstract: Methods, devices, kits and compositions to treat a myocardial infarction. In one embodiment, the method includes the prevention of remodeling of the infarct zone of the ventricle. In other embodiments, the method includes the introduction of structurally reinforcing agents. In other embodiments, agents are introduced into a ventricle to increase compliance of the ventricle. In an alternative embodiment, the prevention of remodeling includes the prevention of thinning of the ventricular infarct zone. In another embodiment, the prevention of remodeling and thinning of the infarct zone involves the cross-linking of collagen and prevention of collagen slipping. In other embodiments, the structurally reinforcing agent may be accompanied by other therapeutic agents. These agents may include but are not limited to pro-fibroblastic and angiogenic agents.
    Type: Application
    Filed: April 15, 2003
    Publication date: October 21, 2004
    Inventors: Eugene T. Michal, Evgenia Mandrusov, Charles D. Claude, Ni Ding, Murthy Simhambhatla, Syed Faiyez Ahmed Hossainy, Srinivasan Sridharan, Paul Consigny